Document Classification

Section Type: RESULTS

Text: Treatment with glargine resulted in lower mean HbA1c (6. 82 + / - 0. 13 vs. 7. 02 + / - 0. 13, difference : 0. 2 + / - 0. 08, P = 0. 026), less nocturnal variability (plasma glucose 49. 06 + / - 4. 74 vs. 62. 36 + / - 5. 21 mg/dl, P = 0. 04), and less hypoglycemia (24. 5 + / - 2. 99 vs. 31. 3 + / - 4. 04 events, P = 0. 05), primarily due to less daytime hypoglycemia (P = 0. 002).